Subtrochanteric Fractures in Bisphosphonate-Naive Patients: Results from the HORIZON-Recurrent Fracture Trial

Por Adachi, Jonathan D., Lyles, Kenneth, Boonen, Steven, Colón-Emeric, Cathleen, Hyldstrup, Lars, Nordsletten, Lars, Pieper, Carl, Recknor, Chris, Su, Guoqin, Bucci-Rechtweg, Christina, Magaziner, Jay
Publicado em 2011

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture

Por Magaziner, Jay S, Orwig, Denise L, Lyles, Kenneth W, Nordsletten, Lars, Boonen, Steven, Adachi, Jonathan D, Recknor, Chris, Colón-Emeric, Cathleen S, Mesenbrink, Peter, Bucci-Rechtweg, Christina, Su, Guoqin, Johnson, Rasheeda, Pieper, Carl F
Publicado no J Bone Miner Res (2014)

The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)

Por Black, Dennis M, Reid, Ian R, Boonen, Steven, Bucci-Rechtweg, Christina, Cauley, Jane A, Cosman, Felicia, Cummings, Steven R, Hue, Trisha F, Lippuner, Kurt, Lakatos, Peter, Leung, Ping Chung, Man, Zulema, Martinez, Ruvie Lou Maria, Tan, Monique, Ruzycky, Mary Ellen, Su, Guoqin, Eastell, Richard
Publicado em 2012